MeSH D012852 - sinusitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012852:Â
Sinusitis
D015521:Ethmoid sinusitis
0 Companies
0 Drugs
Success rate
D015522:Frontal sinusitis
0 Companies
0 Drugs
Success rate
D015523:Maxillary sinusitis
D015524:Sphenoid sinusitis
0 Companies
0 Drugs
Success rate
D000092562:Allergic fungal sinusitis
0 Companies
0 Drugs
Success rate
D000096825:Rhinosinusitis
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Amoxicillin | Amoxicillin |  | 1982-01-01 |  |  |
| Amoxicillin, Clavulanic acid | Amoxicillin Clavulanate Potassium |  | 2004-05-25 |  |  | |
| Cefdinir | Cefdinir |  | 2007-05-04 |  |  | |
| Cefprozil | Cefprozil |  | 2005-12-06 |  |  | |
| Cefuroxime | Cefuroxime |  | 1998-04-16 |  |  | |
| Pseudoephedrine, Cetirizine | Cetirizine Pseudoephedrine |  | 2008-02-25 |  |  | |
| Ciprofloxacin | Ciprofloxacin |  | 2004-06-09 |  |  | |
| Clarithromycin | Clarithromycin |  | 2005-05-31 |  |  | |
| Moxifloxacin | Moxifloxacin |  | 2014-02-18 |  |  | |
| Pseudoephedrine, Triprolidine | Triphed |  | 1984-05-17 |  |  | |
| Pseudoephedrine, Triprolidine | Triprolidine Pseudoephedrine |  | 1984-12-12 |  |  | |
| Padagis | Dextromethorphan, Pseudoephedrine, Brompheniramine | Brompheniramine Maleate, Pseudoephedrine Dextromethorphan |  | 2014-07-15 |  |  |
| Pseudoephedrine, Hydrocodone, Chlorpheniramine | Hydrocodone Bitartrate, Chlorpheniramine Pseudoephedrine |  | 2014-04-29 |  |  | |
| Pseudoephedrine, Hydrocodone | Hydrocodone Pseudoephedrine |  | 2014-04-29 |  |  | |
| Taro Pharmaceutical | Dextromethorphan, Pseudoephedrine, Brompheniramine | Brompheniramine Maleate, Pseudoephedrine Dextromethorphan |  | 2017-02-27 |  |  |
| Ciprofloxacin | Ciprofloxacin |  | 2004-10-06 |  |  | |
| Oxymetazoline | Oxymetazoline |  | 2021-10-04 |  |  | |
| Mylan | Amoxicillin | Amoxicillin |  | 1982-01-01 |  |  |
| Clarithromycin | Clarithromycin |  | 2005-03-11 |  |  | |
| Moxifloxacin | Moxifloxacin |  | 2017-05-05 |  |  | |
| NATCO Pharma | Ciprofloxacin | Ciprofloxacin |  | 2004-06-09 |  |  |
| Moxifloxacin | Moxifloxacin |  | 2015-08-31 |  |  | |
| Mayne Group | Pseudoephedrine, Hydrocodone, Chlorpheniramine | Hydrocodone Bitartrate, Chlorpheniramine Pseudoephedrine |  | 2015-08-03 |  |  |
| Pseudoephedrine, Hydrocodone | Hydrocodone Pseudoephedrine |  | 2015-11-17 |  |  | |
| Oxymetazoline | Rhofade | 2024-01-22 | 2017-01-18 |  |  | |
| Johnson & Johnson | Ibuprofen, Pseudoephedrine | Motrin |  | 2000-08-01 |  |  |
| Ibuprofen, Pseudoephedrine | Sine-aid |  | 1992-12-31 |  |  | |
| Pseudoephedrine | Sudafed |  | 1992-12-15 |  |  | |
| Oxymetazoline | Visine |  | 1989-03-31 |  |  | |
| Pseudoephedrine, Cetirizine | Zyrtec | 2022-06-10 | 2007-11-09 |  |  | |
| Perrigo | Pseudoephedrine, Cetirizine | Cetirizine Pseudoephedrine |  | 2018-11-16 |  |  |
| Guaifenesin | Guaifenesin |  | 2011-11-23 |  |  | |
| Dextromethorphan, Guaifenesin | Guaifenesin Dextromethorphan |  | 2018-03-05 |  |  | |
| Pseudoephedrine, Guaifenesin | Guaifenesin Pseudoephedrine |  | 2022-02-01 |  |  | |
| Ibuprofen, Pseudoephedrine | Ibuprofen Pseudoephedrine |  | 2003-11-05 |  |  | |
| Pseudoephedrine, Loratadine | Loratadine Pseudoephedrine |  | 2004-03-04 |  |  | |
| Pseudoephedrine, Naproxen | Naproxen Pseudoephedrine |  | 2004-03-17 |  |  | |
| Pseudoephedrine | Pseudoephedrine |  | 1999-02-26 |  |  | |
| P&L Developments (PLD) | Pseudoephedrine, Loratadine | Loratadine Pseudoephedrine |  | 2003-02-21 |  |  |
| GSK | Pseudoephedrine, Codeine, Triprolidine | Actifed |  | 1984-04-04 |  |  |
| Ibuprofen, Pseudoephedrine, Chlorpheniramine | Advil |  | 1989-09-19 |  |  | |
| Amoxicillin | Amoxil |  | 1982-01-01 |  |  | |
| Cefuroxime axetil | Ceftin |  | 1987-12-28 |  |  | |
| Amoxicillin | Larotid |  | 1982-01-01 |  |  | |
| Pseudoephedrine | Sudafed |  | 1982-01-01 |  |  |
1
2
3
4
5
6
...
13
>
Clinical Trials
Historical Success Rate
Phase 1
33%1/3
Phase 2
44%12/27
Phase 3
73%30/41
Approved: 19Overall Success rate: 11%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
9
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use